Cargando…
Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival
Multiple myeloma (MM) cells suffer from baseline proteotoxicity as the result of an imbalance between the load of misfolded proteins awaiting proteolysis and the capacity of the ubiquitin-proteasome system to degrade them. This intrinsic vulnerability is at the base of MM sensitivity to agents that...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791580/ https://www.ncbi.nlm.nih.gov/pubmed/34649278 http://dx.doi.org/10.1182/bloodadvances.2020003820 |
_version_ | 1784640214012002304 |
---|---|
author | Chen, Tianzeng Ho, Matthew Briere, Jenna Moscvin, Maria Czarnecki, Peter G. Anderson, Kenneth C. Blackwell, T. Keith Bianchi, Giada |
author_facet | Chen, Tianzeng Ho, Matthew Briere, Jenna Moscvin, Maria Czarnecki, Peter G. Anderson, Kenneth C. Blackwell, T. Keith Bianchi, Giada |
author_sort | Chen, Tianzeng |
collection | PubMed |
description | Multiple myeloma (MM) cells suffer from baseline proteotoxicity as the result of an imbalance between the load of misfolded proteins awaiting proteolysis and the capacity of the ubiquitin-proteasome system to degrade them. This intrinsic vulnerability is at the base of MM sensitivity to agents that perturb proteostasis, such as proteasome inhibitors (PIs), the mainstay of modern-day myeloma therapy. De novo and acquired PI resistance are important clinical limitations that adversely affect prognosis. The molecular mechanisms underpinning PI resistance are only partially understood, limiting the development of drugs that can overcome it. The transcription factor NRF1 is activated by the aspartic protease DNA damage inducible 1 homolog 2 (DDI2) upon proteasome insufficiency and governs proteasome biogenesis. In this article, we show that MM cells exhibit baseline NRF1 activation and are dependent upon DDI2 for survival. DDI2 knockout (KO) is cytotoxic for MM cells, both in vitro and in vivo. Protein structure-function studies show that DDI2 KO blocks NRF1 cleavage and nuclear translocation, causing impaired proteasome activity recovery upon irreversible proteasome inhibition and, thereby, increasing sensitivity to PIs. Add-back of wild-type, but not of catalytically dead DDI2, fully rescues these phenotypes. We propose that DDI2 is an unexplored promising molecular target in MM by disrupting the proteasome stress response and exacerbating proteotoxicity. |
format | Online Article Text |
id | pubmed-8791580 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-87915802022-01-27 Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival Chen, Tianzeng Ho, Matthew Briere, Jenna Moscvin, Maria Czarnecki, Peter G. Anderson, Kenneth C. Blackwell, T. Keith Bianchi, Giada Blood Adv Stimulus Report Multiple myeloma (MM) cells suffer from baseline proteotoxicity as the result of an imbalance between the load of misfolded proteins awaiting proteolysis and the capacity of the ubiquitin-proteasome system to degrade them. This intrinsic vulnerability is at the base of MM sensitivity to agents that perturb proteostasis, such as proteasome inhibitors (PIs), the mainstay of modern-day myeloma therapy. De novo and acquired PI resistance are important clinical limitations that adversely affect prognosis. The molecular mechanisms underpinning PI resistance are only partially understood, limiting the development of drugs that can overcome it. The transcription factor NRF1 is activated by the aspartic protease DNA damage inducible 1 homolog 2 (DDI2) upon proteasome insufficiency and governs proteasome biogenesis. In this article, we show that MM cells exhibit baseline NRF1 activation and are dependent upon DDI2 for survival. DDI2 knockout (KO) is cytotoxic for MM cells, both in vitro and in vivo. Protein structure-function studies show that DDI2 KO blocks NRF1 cleavage and nuclear translocation, causing impaired proteasome activity recovery upon irreversible proteasome inhibition and, thereby, increasing sensitivity to PIs. Add-back of wild-type, but not of catalytically dead DDI2, fully rescues these phenotypes. We propose that DDI2 is an unexplored promising molecular target in MM by disrupting the proteasome stress response and exacerbating proteotoxicity. American Society of Hematology 2022-01-17 /pmc/articles/PMC8791580/ /pubmed/34649278 http://dx.doi.org/10.1182/bloodadvances.2020003820 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
spellingShingle | Stimulus Report Chen, Tianzeng Ho, Matthew Briere, Jenna Moscvin, Maria Czarnecki, Peter G. Anderson, Kenneth C. Blackwell, T. Keith Bianchi, Giada Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival |
title | Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival |
title_full | Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival |
title_fullStr | Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival |
title_full_unstemmed | Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival |
title_short | Multiple myeloma cells depend on the DDI2/NRF1-mediated proteasome stress response for survival |
title_sort | multiple myeloma cells depend on the ddi2/nrf1-mediated proteasome stress response for survival |
topic | Stimulus Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791580/ https://www.ncbi.nlm.nih.gov/pubmed/34649278 http://dx.doi.org/10.1182/bloodadvances.2020003820 |
work_keys_str_mv | AT chentianzeng multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT homatthew multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT brierejenna multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT moscvinmaria multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT czarneckipeterg multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT andersonkennethc multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT blackwelltkeith multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival AT bianchigiada multiplemyelomacellsdependontheddi2nrf1mediatedproteasomestressresponseforsurvival |